Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data.

Massy, Marine, Marti, Stefanie, Hammer, Helly, Hoepner, Robert

DOI: 10.48620/87519
Published: 2025
Container: Not recorded
Publisher: University of Bern
Open access: yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingPublication license: A publication license was supplied: http://purl.org/coar/access_right/c_abf2. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.48620/87519,
  title = {Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data.},
  author = {Massy, Marine and Marti, Stefanie and Hammer, Helly and Hoepner, Robert},
  year = {2025},
  doi = {10.48620/87519},
  url = {https://doi.org/10.48620/87519}
}

RIS

TY  - JOUR
TI  - Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data.
AU  - Massy, Marine
AU  - Marti, Stefanie
AU  - Hammer, Helly
AU  - Hoepner, Robert
PY  - 2025
DO  - 10.48620/87519
UR  - https://doi.org/10.48620/87519
ER  -

APA

Marine, M., Stefanie, M., Helly, H., & Robert, H. (2025). Increased vision impairment reports linked to semaglutide: analysis of FDA adverse event data.. https://doi.org/10.48620/87519

Source records

datacite · retrieved 2026-09-25T04:06:50.380Z